Armata Pharmaceuticals Inc (ARMP)
2.25
+0.15
(+7.14%)
USD |
NYAM |
Nov 22, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Cash from Investing (Quarterly): -0.34M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.34M |
| June 30, 2024 | -1.366M |
| March 31, 2024 | -0.25M |
| December 31, 2023 | -2.39M |
| September 30, 2023 | -3.512M |
| June 30, 2023 | -0.222M |
| March 31, 2023 | -2.01M |
| December 31, 2022 | 0.455M |
| September 30, 2022 | -1.294M |
| June 30, 2022 | -1.136M |
| March 31, 2022 | -0.236M |
| December 31, 2021 | -0.228M |
| September 30, 2021 | -0.582M |
| June 30, 2021 | -0.196M |
| March 31, 2021 | -0.298M |
| December 31, 2020 | -0.366M |
| September 30, 2020 | -0.081M |
| June 30, 2020 | -0.273M |
| March 31, 2020 | -0.104M |
| December 31, 2019 | 0.072M |
| September 30, 2019 | 0.065M |
| June 30, 2019 | 2.882M |
| March 31, 2019 | -0.142M |
| December 31, 2018 | -9.393M |
| Date | Value |
|---|---|
| September 30, 2018 | 9.38M |
| June 30, 2018 | -0.031M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.018M |
| September 30, 2017 | -0.033M |
| June 30, 2017 | -0.002M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | -0.013M |
| September 30, 2016 | -0.029M |
| June 30, 2016 | -0.125M |
| March 31, 2016 | -0.112M |
| December 31, 2015 | -0.05M |
| September 30, 2015 | -0.116M |
| June 30, 2015 | -0.009M |
| March 31, 2015 | -0.035M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | -0.137M |
| June 30, 2014 | -0.831M |
| March 31, 2014 | -0.229M |
| December 31, 2013 | -0.005M |
| September 30, 2013 | -0.032M |
| June 30, 2013 | -0.065M |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.512M
Minimum
Sep 2023
0.455M
Maximum
Dec 2022
-0.7178M
Average
-0.2855M
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.334M |
| Perspective Therapeutics Inc | -29.74M |
| Protalix BioTherapeutics Inc | 20.33M |
| Electromed Inc | -0.058M |
| Xtant Medical Holdings Inc | -2.009M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.863M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow | -42.09M |
| Free Cash Flow Per Share (Quarterly) | -0.2544 |
| Free Cash Flow Yield | -44.90% |